SIG
ALXN

Schooner Investment Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Schooner Investment Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,500
Closed -$237K – 290
2015
Q3 		$237K Hold
1,500
– – 0.17% 146
2015
Q2 		$276K Sell
1,500
-1,000
-40% -$173K 0.13% 223
2015
Q1 		$424K Sell
2,500
-700
-22% -$127K 0.15% 193
2014
Q4 		$597K Buy
+3,200
New +$593K 0.16% 166

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Schooner Investment Group's ALXN Position: Q4 2015 in Review

Schooner Investment Group sold out of Alexion Pharmaceuticals (ALXN) in Q4 2015, closing a stake of 1,500 shares — an estimated $237K sold.

Schooner Investment Group first reported a position in ALXN in Q4 2014 and held it in 4 quarters. The position peaked at $597K in Q4 2014. 547 funds tracked by Wall St. Rank hold ALXN as of Q4 2015.

  • Schooner Investment Group reported no remaining Alexion Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Schooner Investment Group sold 1,500 Alexion Pharmaceuticals shares in Q4 2015, an estimated $237K.
  • Schooner Investment Group first reported a position in Alexion Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Schooner Investment Group's Alexion Pharmaceuticals position peaked at $597K in Q4 2014.
  • 547 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2015.

Based on Schooner Investment Group's 13F filing for Q4 2015, filed 11 Feb 2016.